nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—PTGS1—ulcerative colitis	0.125	0.481	CbGaD
Naproxen—migraine—Prednisone—ulcerative colitis	0.105	0.341	CpDpCtD
Naproxen—osteoarthritis—Prednisone—ulcerative colitis	0.102	0.33	CpDpCtD
Naproxen—osteoarthritis—Methylprednisolone—ulcerative colitis	0.102	0.33	CpDpCtD
Naproxen—PTGS2—ulcerative colitis	0.0713	0.275	CbGaD
Naproxen—ALB—ulcerative colitis	0.0635	0.245	CbGaD
Naproxen—PTGS2—Olsalazine—ulcerative colitis	0.0335	0.106	CbGbCtD
Naproxen—PTGS2—Balsalazide—ulcerative colitis	0.0299	0.0946	CbGbCtD
Naproxen—PTGS1—Olsalazine—ulcerative colitis	0.0283	0.0896	CbGbCtD
Naproxen—PTGS1—Balsalazide—ulcerative colitis	0.0252	0.0799	CbGbCtD
Naproxen—PTGS2—Mesalazine—ulcerative colitis	0.0239	0.0756	CbGbCtD
Naproxen—PTGS1—Mesalazine—ulcerative colitis	0.0202	0.0638	CbGbCtD
Naproxen—SLCO1A2—Prednisolone—ulcerative colitis	0.0138	0.0436	CbGbCtD
Naproxen—PTGS2—Sulfasalazine—ulcerative colitis	0.0133	0.0422	CbGbCtD
Naproxen—PTGS2—Triamcinolone—ulcerative colitis	0.0133	0.0422	CbGbCtD
Naproxen—SLCO1A2—Hydrocortisone—ulcerative colitis	0.0131	0.0414	CbGbCtD
Naproxen—SLCO1A2—Prednisone—ulcerative colitis	0.013	0.0412	CbGbCtD
Naproxen—PTGS2—Betamethasone—ulcerative colitis	0.0114	0.0362	CbGbCtD
Naproxen—PTGS1—Sulfasalazine—ulcerative colitis	0.0113	0.0357	CbGbCtD
Naproxen—CYP2C8—Nicotine—ulcerative colitis	0.00836	0.0265	CbGbCtD
Naproxen—SLCO1A2—Dexamethasone—ulcerative colitis	0.00812	0.0257	CbGbCtD
Naproxen—CYP2C8—Cholecalciferol—ulcerative colitis	0.0075	0.0237	CbGbCtD
Naproxen—ALB—Prednisone—ulcerative colitis	0.00672	0.0213	CbGbCtD
Naproxen—PTGS2—Dexamethasone—ulcerative colitis	0.00666	0.0211	CbGbCtD
Naproxen—CYP1A2—Nicotine—ulcerative colitis	0.00647	0.0205	CbGbCtD
Naproxen—CYP2C9—Nicotine—ulcerative colitis	0.00583	0.0185	CbGbCtD
Naproxen—CYP2C9—Cholecalciferol—ulcerative colitis	0.00523	0.0166	CbGbCtD
Naproxen—CYP2C8—Hydrocortisone—ulcerative colitis	0.00522	0.0165	CbGbCtD
Naproxen—CYP2C8—Dexamethasone—ulcerative colitis	0.00324	0.0103	CbGbCtD
Naproxen—CYP2C9—Dexamethasone—ulcerative colitis	0.00226	0.00716	CbGbCtD
Naproxen—Ketoprofen—CXCR1—ulcerative colitis	0.000534	0.158	CrCbGaD
Naproxen—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000377	0.247	CbGdCrCtD
Naproxen—Nabumetone—MPO—ulcerative colitis	0.000349	0.103	CrCbGaD
Naproxen—Nabumetone—PTGS1—ulcerative colitis	0.000229	0.0678	CrCbGaD
Naproxen—Carprofen—PTGS1—ulcerative colitis	0.000219	0.0647	CrCbGaD
Naproxen—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.000182	0.119	CbGdCrCtD
Naproxen—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000179	0.118	CbGdCrCtD
Naproxen—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000179	0.118	CbGdCrCtD
Naproxen—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000175	0.115	CbGdCrCtD
Naproxen—Indomethacin—CXCL8—ulcerative colitis	0.000168	0.0498	CrCbGaD
Naproxen—Suprofen—PTGS1—ulcerative colitis	0.000135	0.04	CrCbGaD
Naproxen—Ketoprofen—CXCL8—ulcerative colitis	0.000135	0.0398	CrCbGaD
Naproxen—Ibuprofen—CXCL8—ulcerative colitis	0.000133	0.0392	CrCbGaD
Naproxen—Nabumetone—PTGS2—ulcerative colitis	0.000131	0.0388	CrCbGaD
Naproxen—Carprofen—PTGS2—ulcerative colitis	0.000125	0.037	CrCbGaD
Naproxen—Fenoprofen—PTGS1—ulcerative colitis	0.000116	0.0344	CrCbGaD
Naproxen—Indomethacin—PPARG—ulcerative colitis	0.000116	0.0344	CrCbGaD
Naproxen—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.00011	0.0721	CbGdCrCtD
Naproxen—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.000108	0.071	CbGdCrCtD
Naproxen—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.000108	0.071	CbGdCrCtD
Naproxen—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.000106	0.0693	CbGdCrCtD
Naproxen—Ibuprofen—PPARG—ulcerative colitis	9.16e-05	0.0271	CrCbGaD
Naproxen—Indomethacin—PTGS1—ulcerative colitis	8.59e-05	0.0254	CrCbGaD
Naproxen—Suprofen—PTGS2—ulcerative colitis	7.72e-05	0.0228	CrCbGaD
Naproxen—Flurbiprofen—PTGS1—ulcerative colitis	7.6e-05	0.0225	CrCbGaD
Naproxen—Ketoprofen—PTGS1—ulcerative colitis	6.87e-05	0.0203	CrCbGaD
Naproxen—Ibuprofen—PTGS1—ulcerative colitis	6.76e-05	0.02	CrCbGaD
Naproxen—Fenoprofen—PTGS2—ulcerative colitis	6.65e-05	0.0197	CrCbGaD
Naproxen—Fenoprofen—ALB—ulcerative colitis	5.93e-05	0.0175	CrCbGaD
Naproxen—Indomethacin—PTGS2—ulcerative colitis	4.91e-05	0.0145	CrCbGaD
Naproxen—Indomethacin—ALB—ulcerative colitis	4.37e-05	0.0129	CrCbGaD
Naproxen—Flurbiprofen—PTGS2—ulcerative colitis	4.34e-05	0.0128	CrCbGaD
Naproxen—Indomethacin—ABCB1—ulcerative colitis	4.18e-05	0.0124	CrCbGaD
Naproxen—Ketoprofen—PTGS2—ulcerative colitis	3.93e-05	0.0116	CrCbGaD
Naproxen—Flurbiprofen—ALB—ulcerative colitis	3.87e-05	0.0114	CrCbGaD
Naproxen—Ibuprofen—PTGS2—ulcerative colitis	3.87e-05	0.0114	CrCbGaD
Naproxen—Ketoprofen—ALB—ulcerative colitis	3.5e-05	0.0104	CrCbGaD
Naproxen—Ibuprofen—ALB—ulcerative colitis	3.45e-05	0.0102	CrCbGaD
Naproxen—Ibuprofen—ABCB1—ulcerative colitis	3.29e-05	0.00973	CrCbGaD
Naproxen—Arthralgia—Methylprednisolone—ulcerative colitis	3.02e-05	0.000326	CcSEcCtD
Naproxen—Myalgia—Methylprednisolone—ulcerative colitis	3.02e-05	0.000326	CcSEcCtD
Naproxen—Eye disorder—Prednisone—ulcerative colitis	3.01e-05	0.000325	CcSEcCtD
Naproxen—Anxiety—Methylprednisolone—ulcerative colitis	3.01e-05	0.000325	CcSEcCtD
Naproxen—Tachycardia—Hydrocortisone—ulcerative colitis	3.01e-05	0.000324	CcSEcCtD
Naproxen—Rash—Azathioprine—ulcerative colitis	3e-05	0.000324	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	3e-05	0.000324	CcSEcCtD
Naproxen—Dermatitis—Azathioprine—ulcerative colitis	3e-05	0.000323	CcSEcCtD
Naproxen—Skin disorder—Hydrocortisone—ulcerative colitis	2.99e-05	0.000323	CcSEcCtD
Naproxen—Ill-defined disorder—Betamethasone—ulcerative colitis	2.99e-05	0.000323	CcSEcCtD
Naproxen—Ill-defined disorder—Dexamethasone—ulcerative colitis	2.99e-05	0.000323	CcSEcCtD
Naproxen—Discomfort—Triamcinolone—ulcerative colitis	2.99e-05	0.000323	CcSEcCtD
Naproxen—Discomfort—Methylprednisolone—ulcerative colitis	2.98e-05	0.000322	CcSEcCtD
Naproxen—Headache—Azathioprine—ulcerative colitis	2.98e-05	0.000322	CcSEcCtD
Naproxen—Hyperhidrosis—Hydrocortisone—ulcerative colitis	2.98e-05	0.000321	CcSEcCtD
Naproxen—Diarrhoea—Mesalazine—ulcerative colitis	2.96e-05	0.00032	CcSEcCtD
Naproxen—Dry mouth—Triamcinolone—ulcerative colitis	2.96e-05	0.000319	CcSEcCtD
Naproxen—Angioedema—Dexamethasone—ulcerative colitis	2.95e-05	0.000318	CcSEcCtD
Naproxen—Angioedema—Betamethasone—ulcerative colitis	2.95e-05	0.000318	CcSEcCtD
Naproxen—Anorexia—Hydrocortisone—ulcerative colitis	2.94e-05	0.000317	CcSEcCtD
Naproxen—Angiopathy—Prednisone—ulcerative colitis	2.93e-05	0.000316	CcSEcCtD
Naproxen—Confusional state—Methylprednisolone—ulcerative colitis	2.92e-05	0.000315	CcSEcCtD
Naproxen—Immune system disorder—Prednisone—ulcerative colitis	2.91e-05	0.000315	CcSEcCtD
Naproxen—Malaise—Dexamethasone—ulcerative colitis	2.91e-05	0.000314	CcSEcCtD
Naproxen—Malaise—Betamethasone—ulcerative colitis	2.91e-05	0.000314	CcSEcCtD
Naproxen—Oedema—Triamcinolone—ulcerative colitis	2.9e-05	0.000313	CcSEcCtD
Naproxen—Anaphylactic shock—Triamcinolone—ulcerative colitis	2.9e-05	0.000313	CcSEcCtD
Naproxen—Vertigo—Betamethasone—ulcerative colitis	2.9e-05	0.000313	CcSEcCtD
Naproxen—Vertigo—Dexamethasone—ulcerative colitis	2.9e-05	0.000313	CcSEcCtD
Naproxen—Anaphylactic shock—Methylprednisolone—ulcerative colitis	2.89e-05	0.000312	CcSEcCtD
Naproxen—Syncope—Dexamethasone—ulcerative colitis	2.89e-05	0.000312	CcSEcCtD
Naproxen—Syncope—Betamethasone—ulcerative colitis	2.89e-05	0.000312	CcSEcCtD
Naproxen—Arrhythmia—Prednisone—ulcerative colitis	2.88e-05	0.000311	CcSEcCtD
Naproxen—Infection—Triamcinolone—ulcerative colitis	2.88e-05	0.000311	CcSEcCtD
Naproxen—Hypotension—Hydrocortisone—ulcerative colitis	2.88e-05	0.000311	CcSEcCtD
Naproxen—Infection—Methylprednisolone—ulcerative colitis	2.87e-05	0.00031	CcSEcCtD
Naproxen—Dizziness—Mesalazine—ulcerative colitis	2.86e-05	0.000309	CcSEcCtD
Naproxen—Shock—Triamcinolone—ulcerative colitis	2.85e-05	0.000308	CcSEcCtD
Naproxen—Insomnia—Prednisolone—ulcerative colitis	2.85e-05	0.000308	CcSEcCtD
Naproxen—Alopecia—Prednisone—ulcerative colitis	2.85e-05	0.000308	CcSEcCtD
Naproxen—Shock—Methylprednisolone—ulcerative colitis	2.85e-05	0.000307	CcSEcCtD
Naproxen—Nervous system disorder—Methylprednisolone—ulcerative colitis	2.84e-05	0.000306	CcSEcCtD
Naproxen—Loss of consciousness—Betamethasone—ulcerative colitis	2.83e-05	0.000306	CcSEcCtD
Naproxen—Loss of consciousness—Dexamethasone—ulcerative colitis	2.83e-05	0.000306	CcSEcCtD
Naproxen—Paraesthesia—Prednisolone—ulcerative colitis	2.83e-05	0.000306	CcSEcCtD
Naproxen—Tachycardia—Triamcinolone—ulcerative colitis	2.83e-05	0.000306	CcSEcCtD
Naproxen—Mental disorder—Prednisone—ulcerative colitis	2.83e-05	0.000305	CcSEcCtD
Naproxen—Nausea—Azathioprine—ulcerative colitis	2.82e-05	0.000305	CcSEcCtD
Naproxen—Tachycardia—Methylprednisolone—ulcerative colitis	2.82e-05	0.000305	CcSEcCtD
Naproxen—Skin disorder—Methylprednisolone—ulcerative colitis	2.81e-05	0.000303	CcSEcCtD
Naproxen—Malnutrition—Prednisone—ulcerative colitis	2.81e-05	0.000303	CcSEcCtD
Naproxen—Erythema—Prednisone—ulcerative colitis	2.81e-05	0.000303	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	2.81e-05	0.000303	CcSEcCtD
Naproxen—Hyperhidrosis—Triamcinolone—ulcerative colitis	2.8e-05	0.000303	CcSEcCtD
Naproxen—Hyperhidrosis—Methylprednisolone—ulcerative colitis	2.8e-05	0.000302	CcSEcCtD
Naproxen—Convulsion—Dexamethasone—ulcerative colitis	2.79e-05	0.000302	CcSEcCtD
Naproxen—Convulsion—Betamethasone—ulcerative colitis	2.79e-05	0.000302	CcSEcCtD
Naproxen—Insomnia—Hydrocortisone—ulcerative colitis	2.79e-05	0.000301	CcSEcCtD
Naproxen—Hypertension—Dexamethasone—ulcerative colitis	2.78e-05	0.0003	CcSEcCtD
Naproxen—Hypertension—Betamethasone—ulcerative colitis	2.78e-05	0.0003	CcSEcCtD
Naproxen—Paraesthesia—Hydrocortisone—ulcerative colitis	2.77e-05	0.000299	CcSEcCtD
Naproxen—Vomiting—Mesalazine—ulcerative colitis	2.75e-05	0.000297	CcSEcCtD
Naproxen—Myalgia—Dexamethasone—ulcerative colitis	2.75e-05	0.000296	CcSEcCtD
Naproxen—Myalgia—Betamethasone—ulcerative colitis	2.75e-05	0.000296	CcSEcCtD
Naproxen—Anxiety—Betamethasone—ulcerative colitis	2.74e-05	0.000295	CcSEcCtD
Naproxen—Anxiety—Dexamethasone—ulcerative colitis	2.74e-05	0.000295	CcSEcCtD
Naproxen—Rash—Mesalazine—ulcerative colitis	2.73e-05	0.000295	CcSEcCtD
Naproxen—Dermatitis—Mesalazine—ulcerative colitis	2.73e-05	0.000295	CcSEcCtD
Naproxen—Headache—Mesalazine—ulcerative colitis	2.71e-05	0.000293	CcSEcCtD
Naproxen—Discomfort—Dexamethasone—ulcerative colitis	2.71e-05	0.000293	CcSEcCtD
Naproxen—Discomfort—Betamethasone—ulcerative colitis	2.71e-05	0.000293	CcSEcCtD
Naproxen—Dyspepsia—Hydrocortisone—ulcerative colitis	2.71e-05	0.000293	CcSEcCtD
Naproxen—Hypotension—Methylprednisolone—ulcerative colitis	2.7e-05	0.000292	CcSEcCtD
Naproxen—Pain—Prednisolone—ulcerative colitis	2.7e-05	0.000291	CcSEcCtD
Naproxen—Decreased appetite—Hydrocortisone—ulcerative colitis	2.68e-05	0.000289	CcSEcCtD
Naproxen—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	2.66e-05	0.000287	CcSEcCtD
Naproxen—Fatigue—Hydrocortisone—ulcerative colitis	2.66e-05	0.000287	CcSEcCtD
Naproxen—Vision blurred—Prednisone—ulcerative colitis	2.65e-05	0.000286	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	2.64e-05	0.000285	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	2.64e-05	0.000285	CcSEcCtD
Naproxen—Pain—Hydrocortisone—ulcerative colitis	2.63e-05	0.000284	CcSEcCtD
Naproxen—Oedema—Betamethasone—ulcerative colitis	2.63e-05	0.000284	CcSEcCtD
Naproxen—Anaphylactic shock—Dexamethasone—ulcerative colitis	2.63e-05	0.000284	CcSEcCtD
Naproxen—Anaphylactic shock—Betamethasone—ulcerative colitis	2.63e-05	0.000284	CcSEcCtD
Naproxen—Oedema—Dexamethasone—ulcerative colitis	2.63e-05	0.000284	CcSEcCtD
Naproxen—Insomnia—Triamcinolone—ulcerative colitis	2.62e-05	0.000283	CcSEcCtD
Naproxen—Insomnia—Methylprednisolone—ulcerative colitis	2.62e-05	0.000283	CcSEcCtD
Naproxen—Infection—Dexamethasone—ulcerative colitis	2.61e-05	0.000282	CcSEcCtD
Naproxen—Infection—Betamethasone—ulcerative colitis	2.61e-05	0.000282	CcSEcCtD
Naproxen—Ill-defined disorder—Prednisone—ulcerative colitis	2.61e-05	0.000281	CcSEcCtD
Naproxen—Paraesthesia—Triamcinolone—ulcerative colitis	2.6e-05	0.000281	CcSEcCtD
Naproxen—Feeling abnormal—Prednisolone—ulcerative colitis	2.6e-05	0.000281	CcSEcCtD
Naproxen—Paraesthesia—Methylprednisolone—ulcerative colitis	2.6e-05	0.00028	CcSEcCtD
Naproxen—Anaemia—Prednisone—ulcerative colitis	2.6e-05	0.00028	CcSEcCtD
Naproxen—Shock—Dexamethasone—ulcerative colitis	2.59e-05	0.000279	CcSEcCtD
Naproxen—Shock—Betamethasone—ulcerative colitis	2.59e-05	0.000279	CcSEcCtD
Naproxen—Dyspnoea—Triamcinolone—ulcerative colitis	2.59e-05	0.000279	CcSEcCtD
Naproxen—Nervous system disorder—Dexamethasone—ulcerative colitis	2.58e-05	0.000279	CcSEcCtD
Naproxen—Nervous system disorder—Betamethasone—ulcerative colitis	2.58e-05	0.000279	CcSEcCtD
Naproxen—Thrombocytopenia—Betamethasone—ulcerative colitis	2.58e-05	0.000278	CcSEcCtD
Naproxen—Thrombocytopenia—Dexamethasone—ulcerative colitis	2.58e-05	0.000278	CcSEcCtD
Naproxen—Nausea—Mesalazine—ulcerative colitis	2.57e-05	0.000278	CcSEcCtD
Naproxen—Tachycardia—Dexamethasone—ulcerative colitis	2.57e-05	0.000277	CcSEcCtD
Naproxen—Tachycardia—Betamethasone—ulcerative colitis	2.57e-05	0.000277	CcSEcCtD
Naproxen—Angioedema—Prednisone—ulcerative colitis	2.57e-05	0.000277	CcSEcCtD
Naproxen—Dyspepsia—Triamcinolone—ulcerative colitis	2.55e-05	0.000276	CcSEcCtD
Naproxen—Dyspepsia—Methylprednisolone—ulcerative colitis	2.55e-05	0.000275	CcSEcCtD
Naproxen—Hyperhidrosis—Betamethasone—ulcerative colitis	2.54e-05	0.000275	CcSEcCtD
Naproxen—Hyperhidrosis—Dexamethasone—ulcerative colitis	2.54e-05	0.000275	CcSEcCtD
Naproxen—ALB—Vitamin B12 Metabolism—IL1B—ulcerative colitis	2.54e-05	0.00143	CbGpPWpGaD
Naproxen—Feeling abnormal—Hydrocortisone—ulcerative colitis	2.54e-05	0.000274	CcSEcCtD
Naproxen—Malaise—Prednisone—ulcerative colitis	2.53e-05	0.000273	CcSEcCtD
Naproxen—Vertigo—Prednisone—ulcerative colitis	2.52e-05	0.000272	CcSEcCtD
Naproxen—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	2.52e-05	0.000272	CcSEcCtD
Naproxen—Syncope—Prednisone—ulcerative colitis	2.52e-05	0.000272	CcSEcCtD
Naproxen—Anorexia—Dexamethasone—ulcerative colitis	2.51e-05	0.000271	CcSEcCtD
Naproxen—Anorexia—Betamethasone—ulcerative colitis	2.51e-05	0.000271	CcSEcCtD
Naproxen—Urticaria—Prednisolone—ulcerative colitis	2.51e-05	0.00027	CcSEcCtD
Naproxen—Fatigue—Triamcinolone—ulcerative colitis	2.5e-05	0.00027	CcSEcCtD
Naproxen—Fatigue—Methylprednisolone—ulcerative colitis	2.49e-05	0.000269	CcSEcCtD
Naproxen—PTGS2—Selenium Micronutrient Network—ALB—ulcerative colitis	2.49e-05	0.00141	CbGpPWpGaD
Naproxen—Pain—Triamcinolone—ulcerative colitis	2.48e-05	0.000268	CcSEcCtD
Naproxen—PTGS2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	2.48e-05	0.0014	CbGpPWpGaD
Naproxen—Loss of consciousness—Prednisone—ulcerative colitis	2.47e-05	0.000266	CcSEcCtD
Naproxen—PTGS2—Spinal Cord Injury—TLR4—ulcerative colitis	2.47e-05	0.00139	CbGpPWpGaD
Naproxen—Hypotension—Betamethasone—ulcerative colitis	2.46e-05	0.000265	CcSEcCtD
Naproxen—Hypotension—Dexamethasone—ulcerative colitis	2.46e-05	0.000265	CcSEcCtD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.45e-05	0.00138	CbGpPWpGaD
Naproxen—Urticaria—Hydrocortisone—ulcerative colitis	2.45e-05	0.000264	CcSEcCtD
Naproxen—Body temperature increased—Hydrocortisone—ulcerative colitis	2.43e-05	0.000263	CcSEcCtD
Naproxen—Abdominal pain—Hydrocortisone—ulcerative colitis	2.43e-05	0.000263	CcSEcCtD
Naproxen—Convulsion—Prednisone—ulcerative colitis	2.43e-05	0.000263	CcSEcCtD
Naproxen—Hypertension—Prednisone—ulcerative colitis	2.42e-05	0.000262	CcSEcCtD
Naproxen—ALB—Selenium Micronutrient Network—ICAM1—ulcerative colitis	2.42e-05	0.00137	CbGpPWpGaD
Naproxen—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	2.4e-05	0.000259	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	2.4e-05	0.000259	CcSEcCtD
Naproxen—AKR1C3—Disease—SLC11A1—ulcerative colitis	2.4e-05	0.00135	CbGpPWpGaD
Naproxen—Myalgia—Prednisone—ulcerative colitis	2.39e-05	0.000258	CcSEcCtD
Naproxen—Arthralgia—Prednisone—ulcerative colitis	2.39e-05	0.000258	CcSEcCtD
Naproxen—Feeling abnormal—Triamcinolone—ulcerative colitis	2.39e-05	0.000258	CcSEcCtD
Naproxen—PTGS1—Selenium Micronutrient Network—NFKB1—ulcerative colitis	2.39e-05	0.00135	CbGpPWpGaD
Naproxen—Feeling abnormal—Methylprednisolone—ulcerative colitis	2.38e-05	0.000257	CcSEcCtD
Naproxen—Anxiety—Prednisone—ulcerative colitis	2.38e-05	0.000257	CcSEcCtD
Naproxen—Insomnia—Betamethasone—ulcerative colitis	2.38e-05	0.000257	CcSEcCtD
Naproxen—Insomnia—Dexamethasone—ulcerative colitis	2.38e-05	0.000257	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	2.37e-05	0.000256	CcSEcCtD
Naproxen—ALB—Vitamin B12 Metabolism—NFKB1—ulcerative colitis	2.37e-05	0.00134	CbGpPWpGaD
Naproxen—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	2.37e-05	0.000255	CcSEcCtD
Naproxen—PTGS2—Spinal Cord Injury—ICAM1—ulcerative colitis	2.37e-05	0.00134	CbGpPWpGaD
Naproxen—Paraesthesia—Dexamethasone—ulcerative colitis	2.36e-05	0.000255	CcSEcCtD
Naproxen—Paraesthesia—Betamethasone—ulcerative colitis	2.36e-05	0.000255	CcSEcCtD
Naproxen—Discomfort—Prednisone—ulcerative colitis	2.36e-05	0.000255	CcSEcCtD
Naproxen—ALB—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	2.36e-05	0.00133	CbGpPWpGaD
Naproxen—Hypersensitivity—Prednisolone—ulcerative colitis	2.32e-05	0.000251	CcSEcCtD
Naproxen—ALB—Folate Metabolism—IFNG—ulcerative colitis	2.32e-05	0.00131	CbGpPWpGaD
Naproxen—Dyspepsia—Betamethasone—ulcerative colitis	2.32e-05	0.00025	CcSEcCtD
Naproxen—Dyspepsia—Dexamethasone—ulcerative colitis	2.32e-05	0.00025	CcSEcCtD
Naproxen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	2.32e-05	0.00131	CbGpPWpGaD
Naproxen—Urticaria—Triamcinolone—ulcerative colitis	2.3e-05	0.000249	CcSEcCtD
Naproxen—SLC22A6—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.3e-05	0.0013	CbGpPWpGaD
Naproxen—Urticaria—Methylprednisolone—ulcerative colitis	2.3e-05	0.000248	CcSEcCtD
Naproxen—Body temperature increased—Triamcinolone—ulcerative colitis	2.29e-05	0.000247	CcSEcCtD
Naproxen—Anaphylactic shock—Prednisone—ulcerative colitis	2.29e-05	0.000247	CcSEcCtD
Naproxen—Oedema—Prednisone—ulcerative colitis	2.29e-05	0.000247	CcSEcCtD
Naproxen—Abdominal pain—Methylprednisolone—ulcerative colitis	2.29e-05	0.000247	CcSEcCtD
Naproxen—Decreased appetite—Dexamethasone—ulcerative colitis	2.29e-05	0.000247	CcSEcCtD
Naproxen—Decreased appetite—Betamethasone—ulcerative colitis	2.29e-05	0.000247	CcSEcCtD
Naproxen—ALB—Folate Metabolism—RELA—ulcerative colitis	2.29e-05	0.00129	CbGpPWpGaD
Naproxen—PTGS2—C-MYB transcription factor network—CD4—ulcerative colitis	2.28e-05	0.00129	CbGpPWpGaD
Naproxen—Infection—Prednisone—ulcerative colitis	2.28e-05	0.000246	CcSEcCtD
Naproxen—PTGS2—Selenium Micronutrient Network—IFNG—ulcerative colitis	2.28e-05	0.00129	CbGpPWpGaD
Naproxen—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	2.27e-05	0.000245	CcSEcCtD
Naproxen—Gastrointestinal disorder—Betamethasone—ulcerative colitis	2.27e-05	0.000245	CcSEcCtD
Naproxen—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	2.27e-05	0.00128	CbGpPWpGaD
Naproxen—Hypersensitivity—Hydrocortisone—ulcerative colitis	2.27e-05	0.000245	CcSEcCtD
Naproxen—Fatigue—Dexamethasone—ulcerative colitis	2.27e-05	0.000245	CcSEcCtD
Naproxen—Fatigue—Betamethasone—ulcerative colitis	2.27e-05	0.000245	CcSEcCtD
Naproxen—SLCO1A2—Metabolism—CHP1—ulcerative colitis	2.26e-05	0.00128	CbGpPWpGaD
Naproxen—Shock—Prednisone—ulcerative colitis	2.25e-05	0.000243	CcSEcCtD
Naproxen—Pain—Betamethasone—ulcerative colitis	2.25e-05	0.000243	CcSEcCtD
Naproxen—Pain—Dexamethasone—ulcerative colitis	2.25e-05	0.000243	CcSEcCtD
Naproxen—Nervous system disorder—Prednisone—ulcerative colitis	2.25e-05	0.000243	CcSEcCtD
Naproxen—PTGS2—Selenium Micronutrient Network—RELA—ulcerative colitis	2.25e-05	0.00127	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—DLD—ulcerative colitis	2.24e-05	0.00127	CbGpPWpGaD
Naproxen—Tachycardia—Prednisone—ulcerative colitis	2.24e-05	0.000241	CcSEcCtD
Naproxen—Skin disorder—Prednisone—ulcerative colitis	2.23e-05	0.00024	CcSEcCtD
Naproxen—Hyperhidrosis—Prednisone—ulcerative colitis	2.22e-05	0.000239	CcSEcCtD
Naproxen—Asthenia—Hydrocortisone—ulcerative colitis	2.21e-05	0.000239	CcSEcCtD
Naproxen—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	2.21e-05	0.00125	CbGpPWpGaD
Naproxen—Anorexia—Prednisone—ulcerative colitis	2.18e-05	0.000236	CcSEcCtD
Naproxen—Pruritus—Hydrocortisone—ulcerative colitis	2.18e-05	0.000235	CcSEcCtD
Naproxen—Feeling abnormal—Dexamethasone—ulcerative colitis	2.17e-05	0.000234	CcSEcCtD
Naproxen—Feeling abnormal—Betamethasone—ulcerative colitis	2.17e-05	0.000234	CcSEcCtD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	2.16e-05	0.00122	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CXCR1—ulcerative colitis	2.16e-05	0.00122	CbGpPWpGaD
Naproxen—AKR1C3—Disease—MAML2—ulcerative colitis	2.15e-05	0.00122	CbGpPWpGaD
Naproxen—Gastrointestinal pain—Betamethasone—ulcerative colitis	2.15e-05	0.000232	CcSEcCtD
Naproxen—Gastrointestinal pain—Dexamethasone—ulcerative colitis	2.15e-05	0.000232	CcSEcCtD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	2.15e-05	0.00121	CbGpPWpGaD
Naproxen—Hypersensitivity—Triamcinolone—ulcerative colitis	2.14e-05	0.000231	CcSEcCtD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	2.14e-05	0.00121	CbGpPWpGaD
Naproxen—Hypersensitivity—Methylprednisolone—ulcerative colitis	2.13e-05	0.00023	CcSEcCtD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.12e-05	0.0012	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CHP1—ulcerative colitis	2.11e-05	0.00119	CbGpPWpGaD
Naproxen—Diarrhoea—Hydrocortisone—ulcerative colitis	2.11e-05	0.000227	CcSEcCtD
Naproxen—Urticaria—Dexamethasone—ulcerative colitis	2.09e-05	0.000226	CcSEcCtD
Naproxen—Urticaria—Betamethasone—ulcerative colitis	2.09e-05	0.000226	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Prednisone—ulcerative colitis	2.09e-05	0.000225	CcSEcCtD
Naproxen—Dizziness—Prednisolone—ulcerative colitis	2.09e-05	0.000225	CcSEcCtD
Naproxen—Asthenia—Triamcinolone—ulcerative colitis	2.08e-05	0.000225	CcSEcCtD
Naproxen—Abdominal pain—Dexamethasone—ulcerative colitis	2.08e-05	0.000225	CcSEcCtD
Naproxen—Body temperature increased—Dexamethasone—ulcerative colitis	2.08e-05	0.000225	CcSEcCtD
Naproxen—Body temperature increased—Betamethasone—ulcerative colitis	2.08e-05	0.000225	CcSEcCtD
Naproxen—Abdominal pain—Betamethasone—ulcerative colitis	2.08e-05	0.000225	CcSEcCtD
Naproxen—Asthenia—Methylprednisolone—ulcerative colitis	2.08e-05	0.000224	CcSEcCtD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	2.08e-05	0.00117	CbGpPWpGaD
Naproxen—Insomnia—Prednisone—ulcerative colitis	2.07e-05	0.000224	CcSEcCtD
Naproxen—ALB—Folate Metabolism—IL1B—ulcerative colitis	2.07e-05	0.00117	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL2—ulcerative colitis	2.06e-05	0.00116	CbGpPWpGaD
Naproxen—Paraesthesia—Prednisone—ulcerative colitis	2.06e-05	0.000222	CcSEcCtD
Naproxen—Pruritus—Triamcinolone—ulcerative colitis	2.05e-05	0.000221	CcSEcCtD
Naproxen—Pruritus—Methylprednisolone—ulcerative colitis	2.05e-05	0.000221	CcSEcCtD
Naproxen—Dizziness—Hydrocortisone—ulcerative colitis	2.04e-05	0.00022	CcSEcCtD
Naproxen—PTGS2—Selenium Micronutrient Network—IL1B—ulcerative colitis	2.03e-05	0.00115	CbGpPWpGaD
Naproxen—Dyspepsia—Prednisone—ulcerative colitis	2.02e-05	0.000218	CcSEcCtD
Naproxen—UGT2B7—NRF2 pathway—TGFB1—ulcerative colitis	2e-05	0.00113	CbGpPWpGaD
Naproxen—Decreased appetite—Prednisone—ulcerative colitis	1.99e-05	0.000215	CcSEcCtD
Naproxen—Rash—Prednisolone—ulcerative colitis	1.99e-05	0.000215	CcSEcCtD
Naproxen—Dermatitis—Prednisolone—ulcerative colitis	1.99e-05	0.000214	CcSEcCtD
Naproxen—ALB—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	1.99e-05	0.00112	CbGpPWpGaD
Naproxen—Diarrhoea—Methylprednisolone—ulcerative colitis	1.98e-05	0.000214	CcSEcCtD
Naproxen—Fatigue—Prednisone—ulcerative colitis	1.98e-05	0.000213	CcSEcCtD
Naproxen—Headache—Prednisolone—ulcerative colitis	1.98e-05	0.000213	CcSEcCtD
Naproxen—Constipation—Prednisone—ulcerative colitis	1.96e-05	0.000212	CcSEcCtD
Naproxen—Vomiting—Hydrocortisone—ulcerative colitis	1.96e-05	0.000211	CcSEcCtD
Naproxen—SLCO1A2—Metabolism—DLD—ulcerative colitis	1.95e-05	0.0011	CbGpPWpGaD
Naproxen—Rash—Hydrocortisone—ulcerative colitis	1.94e-05	0.00021	CcSEcCtD
Naproxen—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	1.94e-05	0.0011	CbGpPWpGaD
Naproxen—Dermatitis—Hydrocortisone—ulcerative colitis	1.94e-05	0.000209	CcSEcCtD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	1.93e-05	0.00109	CbGpPWpGaD
Naproxen—Headache—Hydrocortisone—ulcerative colitis	1.93e-05	0.000208	CcSEcCtD
Naproxen—ALB—Folate Metabolism—NFKB1—ulcerative colitis	1.93e-05	0.00109	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	1.92e-05	0.00109	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	1.92e-05	0.00109	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	1.92e-05	0.00109	CbGpPWpGaD
Naproxen—Dizziness—Triamcinolone—ulcerative colitis	1.92e-05	0.000207	CcSEcCtD
Naproxen—Dizziness—Methylprednisolone—ulcerative colitis	1.91e-05	0.000207	CcSEcCtD
Naproxen—AKR1C3—Signaling Pathways—CCL20—ulcerative colitis	1.9e-05	0.00107	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	1.89e-05	0.00107	CbGpPWpGaD
Naproxen—Feeling abnormal—Prednisone—ulcerative colitis	1.89e-05	0.000204	CcSEcCtD
Naproxen—Asthenia—Betamethasone—ulcerative colitis	1.89e-05	0.000204	CcSEcCtD
Naproxen—Asthenia—Dexamethasone—ulcerative colitis	1.89e-05	0.000204	CcSEcCtD
Naproxen—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	1.89e-05	0.00106	CbGpPWpGaD
Naproxen—Gastrointestinal pain—Prednisone—ulcerative colitis	1.87e-05	0.000202	CcSEcCtD
Naproxen—Nausea—Prednisolone—ulcerative colitis	1.87e-05	0.000202	CcSEcCtD
Naproxen—Pruritus—Betamethasone—ulcerative colitis	1.86e-05	0.000201	CcSEcCtD
Naproxen—Pruritus—Dexamethasone—ulcerative colitis	1.86e-05	0.000201	CcSEcCtD
Naproxen—PTGS1—Selenium Micronutrient Network—TNF—ulcerative colitis	1.86e-05	0.00105	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—TNF—ulcerative colitis	1.84e-05	0.00104	CbGpPWpGaD
Naproxen—Vomiting—Triamcinolone—ulcerative colitis	1.84e-05	0.000199	CcSEcCtD
Naproxen—ALB—Selenium Micronutrient Network—IFNG—ulcerative colitis	1.84e-05	0.00104	CbGpPWpGaD
Naproxen—Vomiting—Methylprednisolone—ulcerative colitis	1.84e-05	0.000199	CcSEcCtD
Naproxen—Nausea—Hydrocortisone—ulcerative colitis	1.83e-05	0.000197	CcSEcCtD
Naproxen—Rash—Triamcinolone—ulcerative colitis	1.83e-05	0.000197	CcSEcCtD
Naproxen—Dermatitis—Triamcinolone—ulcerative colitis	1.83e-05	0.000197	CcSEcCtD
Naproxen—Rash—Methylprednisolone—ulcerative colitis	1.82e-05	0.000197	CcSEcCtD
Naproxen—Dermatitis—Methylprednisolone—ulcerative colitis	1.82e-05	0.000197	CcSEcCtD
Naproxen—UGT1A1—Metabolism—DLD—ulcerative colitis	1.82e-05	0.00103	CbGpPWpGaD
Naproxen—Urticaria—Prednisone—ulcerative colitis	1.82e-05	0.000197	CcSEcCtD
Naproxen—ALB—Selenium Micronutrient Network—RELA—ulcerative colitis	1.82e-05	0.00103	CbGpPWpGaD
Naproxen—Headache—Triamcinolone—ulcerative colitis	1.82e-05	0.000196	CcSEcCtD
Naproxen—Headache—Methylprednisolone—ulcerative colitis	1.81e-05	0.000196	CcSEcCtD
Naproxen—Abdominal pain—Prednisone—ulcerative colitis	1.81e-05	0.000196	CcSEcCtD
Naproxen—Body temperature increased—Prednisone—ulcerative colitis	1.81e-05	0.000196	CcSEcCtD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.8e-05	0.00102	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	1.8e-05	0.00102	CbGpPWpGaD
Naproxen—Diarrhoea—Betamethasone—ulcerative colitis	1.8e-05	0.000194	CcSEcCtD
Naproxen—Diarrhoea—Dexamethasone—ulcerative colitis	1.8e-05	0.000194	CcSEcCtD
Naproxen—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	1.8e-05	0.00102	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—GNA12—ulcerative colitis	1.78e-05	0.00101	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CALM3—ulcerative colitis	1.77e-05	0.001	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—PTGS2—ulcerative colitis	1.77e-05	0.000997	CbGpPWpGaD
Naproxen—Dizziness—Betamethasone—ulcerative colitis	1.74e-05	0.000188	CcSEcCtD
Naproxen—Dizziness—Dexamethasone—ulcerative colitis	1.74e-05	0.000188	CcSEcCtD
Naproxen—SLCO1A2—SLC-mediated transmembrane transport—ALB—ulcerative colitis	1.74e-05	0.00098	CbGpPWpGaD
Naproxen—Nausea—Triamcinolone—ulcerative colitis	1.72e-05	0.000186	CcSEcCtD
Naproxen—PTGS1—Metabolism—CHP1—ulcerative colitis	1.72e-05	0.000971	CbGpPWpGaD
Naproxen—Nausea—Methylprednisolone—ulcerative colitis	1.72e-05	0.000186	CcSEcCtD
Naproxen—AKR1C3—Signaling Pathways—CXCR2—ulcerative colitis	1.69e-05	0.000955	CbGpPWpGaD
Naproxen—Hypersensitivity—Prednisone—ulcerative colitis	1.69e-05	0.000182	CcSEcCtD
Naproxen—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	1.67e-05	0.000945	CbGpPWpGaD
Naproxen—Vomiting—Betamethasone—ulcerative colitis	1.67e-05	0.000181	CcSEcCtD
Naproxen—Vomiting—Dexamethasone—ulcerative colitis	1.67e-05	0.000181	CcSEcCtD
Naproxen—Rash—Dexamethasone—ulcerative colitis	1.66e-05	0.000179	CcSEcCtD
Naproxen—Rash—Betamethasone—ulcerative colitis	1.66e-05	0.000179	CcSEcCtD
Naproxen—Dermatitis—Betamethasone—ulcerative colitis	1.66e-05	0.000179	CcSEcCtD
Naproxen—Dermatitis—Dexamethasone—ulcerative colitis	1.66e-05	0.000179	CcSEcCtD
Naproxen—AKR1C3—Metabolism—PTGS1—ulcerative colitis	1.65e-05	0.000931	CbGpPWpGaD
Naproxen—Headache—Betamethasone—ulcerative colitis	1.65e-05	0.000178	CcSEcCtD
Naproxen—Headache—Dexamethasone—ulcerative colitis	1.65e-05	0.000178	CcSEcCtD
Naproxen—Asthenia—Prednisone—ulcerative colitis	1.64e-05	0.000177	CcSEcCtD
Naproxen—ALB—Selenium Micronutrient Network—IL1B—ulcerative colitis	1.64e-05	0.000928	CbGpPWpGaD
Naproxen—SLC22A6—SLC-mediated transmembrane transport—ALB—ulcerative colitis	1.63e-05	0.000921	CbGpPWpGaD
Naproxen—PTGS2—Disease—CHP1—ulcerative colitis	1.63e-05	0.00092	CbGpPWpGaD
Naproxen—UGT1A1—NRF2 pathway—TGFB1—ulcerative colitis	1.63e-05	0.000918	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.62e-05	0.000916	CbGpPWpGaD
Naproxen—Pruritus—Prednisone—ulcerative colitis	1.62e-05	0.000175	CcSEcCtD
Naproxen—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	1.61e-05	0.000907	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	1.6e-05	0.000903	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CCR6—ulcerative colitis	1.59e-05	0.000898	CbGpPWpGaD
Naproxen—Diarrhoea—Prednisone—ulcerative colitis	1.57e-05	0.000169	CcSEcCtD
Naproxen—Nausea—Betamethasone—ulcerative colitis	1.56e-05	0.000169	CcSEcCtD
Naproxen—Nausea—Dexamethasone—ulcerative colitis	1.56e-05	0.000169	CcSEcCtD
Naproxen—ALB—Selenium Micronutrient Network—NFKB1—ulcerative colitis	1.53e-05	0.000865	CbGpPWpGaD
Naproxen—Dizziness—Prednisone—ulcerative colitis	1.52e-05	0.000164	CcSEcCtD
Naproxen—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	1.51e-05	0.000855	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MAML2—ulcerative colitis	1.51e-05	0.000851	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—TNF—ulcerative colitis	1.5e-05	0.000847	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	1.5e-05	0.000847	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—IL6—ulcerative colitis	1.5e-05	0.000846	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—IL6—ulcerative colitis	1.49e-05	0.00084	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—CALM3—ulcerative colitis	1.48e-05	0.000838	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—DLD—ulcerative colitis	1.48e-05	0.000838	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	1.47e-05	0.000832	CbGpPWpGaD
Naproxen—ALB—Hemostasis—GNA12—ulcerative colitis	1.47e-05	0.000831	CbGpPWpGaD
Naproxen—Vomiting—Prednisone—ulcerative colitis	1.46e-05	0.000157	CcSEcCtD
Naproxen—Rash—Prednisone—ulcerative colitis	1.44e-05	0.000156	CcSEcCtD
Naproxen—ALB—Hemostasis—ITGAL—ulcerative colitis	1.44e-05	0.000815	CbGpPWpGaD
Naproxen—Dermatitis—Prednisone—ulcerative colitis	1.44e-05	0.000156	CcSEcCtD
Naproxen—Headache—Prednisone—ulcerative colitis	1.44e-05	0.000155	CcSEcCtD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.42e-05	0.000801	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.41e-05	0.000796	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	1.4e-05	0.000791	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	1.4e-05	0.000791	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—PTGER4—ulcerative colitis	1.4e-05	0.00079	CbGpPWpGaD
Naproxen—ALB—Platelet degranulation—TGFB1—ulcerative colitis	1.38e-05	0.000778	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CHP1—ulcerative colitis	1.37e-05	0.000771	CbGpPWpGaD
Naproxen—Nausea—Prednisone—ulcerative colitis	1.36e-05	0.000147	CcSEcCtD
Naproxen—SLC22A6—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.33e-05	0.000749	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—TP53—ulcerative colitis	1.32e-05	0.000747	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.32e-05	0.000743	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	1.31e-05	0.000741	CbGpPWpGaD
Naproxen—PTGS2—Disease—SEL1L—ulcerative colitis	1.3e-05	0.000731	CbGpPWpGaD
Naproxen—AKR1C3—Disease—ADCY5—ulcerative colitis	1.29e-05	0.000726	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—GHRL—ulcerative colitis	1.28e-05	0.000724	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.28e-05	0.000722	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	1.25e-05	0.000705	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CALM3—ulcerative colitis	1.24e-05	0.000701	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.24e-05	0.000698	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—RIPK2—ulcerative colitis	1.22e-05	0.00069	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL6—ulcerative colitis	1.21e-05	0.000684	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.2e-05	0.000676	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	1.19e-05	0.000673	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	1.19e-05	0.000671	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—DLD—ulcerative colitis	1.18e-05	0.000665	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	1.17e-05	0.000658	CbGpPWpGaD
Naproxen—PTGS2—Disease—LTF—ulcerative colitis	1.16e-05	0.000656	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—ABCB1—ulcerative colitis	1.15e-05	0.000652	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CHP1—ulcerative colitis	1.11e-05	0.000627	CbGpPWpGaD
Naproxen—ALB—Metabolism—CHP1—ulcerative colitis	1.1e-05	0.000624	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PTGS1—ulcerative colitis	1.08e-05	0.000612	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—ADCY5—ulcerative colitis	1.08e-05	0.000608	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—ADRB2—ulcerative colitis	1.06e-05	0.000599	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.04e-05	0.000588	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.03e-05	0.000584	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.03e-05	0.000583	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	1.03e-05	0.00058	CbGpPWpGaD
Naproxen—ALB—Hemostasis—CALM3—ulcerative colitis	1.02e-05	0.000578	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.02e-05	0.000575	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CALM3—ulcerative colitis	9.75e-06	0.000551	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	9.62e-06	0.000543	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—DLD—ulcerative colitis	9.59e-06	0.000541	CbGpPWpGaD
Naproxen—ALB—Metabolism—DLD—ulcerative colitis	9.53e-06	0.000538	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PTGS1—ulcerative colitis	9.43e-06	0.000533	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	9.4e-06	0.000531	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9.28e-06	0.000524	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CHP1—ulcerative colitis	9.04e-06	0.00051	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—ADCY5—ulcerative colitis	9.01e-06	0.000508	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	8.98e-06	0.000507	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	8.82e-06	0.000498	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PTGS1—ulcerative colitis	8.8e-06	0.000497	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CALM3—ulcerative colitis	8.49e-06	0.00048	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	8.49e-06	0.000479	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	8.47e-06	0.000478	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—ALB—ulcerative colitis	8.29e-06	0.000468	CbGpPWpGaD
Naproxen—PTGS2—Disease—SLC11A1—ulcerative colitis	8.28e-06	0.000467	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.12e-06	0.000458	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PPARG—ulcerative colitis	8.03e-06	0.000454	CbGpPWpGaD
Naproxen—AKR1C3—Disease—JAK2—ulcerative colitis	8.02e-06	0.000453	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CALM3—ulcerative colitis	7.93e-06	0.000448	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	7.93e-06	0.000448	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.85e-06	0.000443	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	7.83e-06	0.000442	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—DLD—ulcerative colitis	7.8e-06	0.000441	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CHP1—ulcerative colitis	7.73e-06	0.000436	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CD4—ulcerative colitis	7.6e-06	0.000429	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ABCB1—ulcerative colitis	7.59e-06	0.000428	CbGpPWpGaD
Naproxen—AKR1C3—Disease—PTGS2—ulcerative colitis	7.54e-06	0.000426	CbGpPWpGaD
Naproxen—PTGS2—Disease—MAML2—ulcerative colitis	7.44e-06	0.00042	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	7.24e-06	0.000409	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—ALB—ulcerative colitis	7.22e-06	0.000408	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ADCY5—ulcerative colitis	7.08e-06	0.0004	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.06e-06	0.000399	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	6.99e-06	0.000395	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	6.89e-06	0.000389	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—DLD—ulcerative colitis	6.67e-06	0.000377	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ABCB1—ulcerative colitis	6.61e-06	0.000373	CbGpPWpGaD
Naproxen—ALB—Hemostasis—MMP1—ulcerative colitis	6.57e-06	0.000371	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CALM3—ulcerative colitis	6.46e-06	0.000365	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	6.43e-06	0.000363	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PTGS2—ulcerative colitis	6.32e-06	0.000357	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.23e-06	0.000352	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.18e-06	0.000349	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ABCB1—ulcerative colitis	6.16e-06	0.000348	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ADCY5—ulcerative colitis	6.16e-06	0.000348	CbGpPWpGaD
Naproxen—PTGS2—Disease—CALM3—ulcerative colitis	6.13e-06	0.000346	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	6.11e-06	0.000345	CbGpPWpGaD
Naproxen—AKR1C3—Disease—STAT3—ulcerative colitis	5.88e-06	0.000332	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ADCY5—ulcerative colitis	5.75e-06	0.000325	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PTGS1—ulcerative colitis	5.7e-06	0.000322	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—JAK2—ulcerative colitis	5.61e-06	0.000317	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.6e-06	0.000316	CbGpPWpGaD
Naproxen—AKR1C3—Disease—TGFB1—ulcerative colitis	5.45e-06	0.000308	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—RELA—ulcerative colitis	5.44e-06	0.000307	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PPARG—ulcerative colitis	5.28e-06	0.000298	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CALM3—ulcerative colitis	5.13e-06	0.00029	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CXCL8—ulcerative colitis	5.12e-06	0.000289	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.07e-06	0.000286	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.04e-06	0.000285	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ABCB1—ulcerative colitis	5.03e-06	0.000284	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL2—ulcerative colitis	4.9e-06	0.000276	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ALB—ulcerative colitis	4.75e-06	0.000268	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ADCY5—ulcerative colitis	4.69e-06	0.000265	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PTGS1—ulcerative colitis	4.64e-06	0.000262	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MMP9—ulcerative colitis	4.63e-06	0.000262	CbGpPWpGaD
Naproxen—ALB—Hemostasis—JAK2—ulcerative colitis	4.63e-06	0.000261	CbGpPWpGaD
Naproxen—ALB—Metabolism—PTGS1—ulcerative colitis	4.61e-06	0.00026	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PPARG—ulcerative colitis	4.6e-06	0.000259	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—NFKB1—ulcerative colitis	4.59e-06	0.000259	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.56e-06	0.000257	CbGpPWpGaD
Naproxen—PTGS2—Disease—ADCY5—ulcerative colitis	4.44e-06	0.000251	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PPARG—ulcerative colitis	4.29e-06	0.000242	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CALM3—ulcerative colitis	4.17e-06	0.000236	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PTGS2—ulcerative colitis	4.15e-06	0.000234	CbGpPWpGaD
Naproxen—ALB—Metabolism—CALM3—ulcerative colitis	4.15e-06	0.000234	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ALB—ulcerative colitis	4.13e-06	0.000233	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.13e-06	0.000233	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—STAT3—ulcerative colitis	4.12e-06	0.000233	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IL6—ulcerative colitis	4.11e-06	0.000232	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IL2—ulcerative colitis	4.04e-06	0.000228	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ABCB1—ulcerative colitis	3.99e-06	0.000225	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.99e-06	0.000225	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.97e-06	0.000224	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ALB—ulcerative colitis	3.86e-06	0.000218	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TGFB1—ulcerative colitis	3.82e-06	0.000216	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PTGS1—ulcerative colitis	3.77e-06	0.000213	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ADCY5—ulcerative colitis	3.72e-06	0.00021	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.71e-06	0.00021	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PTGS2—ulcerative colitis	3.62e-06	0.000204	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.53e-06	0.000199	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PPARG—ulcerative colitis	3.5e-06	0.000197	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CALM3—ulcerative colitis	3.4e-06	0.000192	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PTGS2—ulcerative colitis	3.37e-06	0.00019	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.25e-06	0.000183	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ABCB1—ulcerative colitis	3.25e-06	0.000183	CbGpPWpGaD
Naproxen—ALB—Metabolism—ABCB1—ulcerative colitis	3.23e-06	0.000182	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PTGS1—ulcerative colitis	3.22e-06	0.000182	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.17e-06	0.000179	CbGpPWpGaD
Naproxen—ALB—Hemostasis—TGFB1—ulcerative colitis	3.15e-06	0.000178	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TP53—ulcerative colitis	3.14e-06	0.000178	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ALB—ulcerative colitis	3.14e-06	0.000178	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ADCY5—ulcerative colitis	3.03e-06	0.000171	CbGpPWpGaD
Naproxen—ALB—Metabolism—ADCY5—ulcerative colitis	3.01e-06	0.00017	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CALM3—ulcerative colitis	2.9e-06	0.000164	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6—ulcerative colitis	2.88e-06	0.000163	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPARG—ulcerative colitis	2.78e-06	0.000157	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.77e-06	0.000157	CbGpPWpGaD
Naproxen—PTGS2—Disease—JAK2—ulcerative colitis	2.77e-06	0.000156	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PTGS2—ulcerative colitis	2.75e-06	0.000155	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ABCB1—ulcerative colitis	2.64e-06	0.000149	CbGpPWpGaD
Naproxen—PTGS2—Disease—CD4—ulcerative colitis	2.63e-06	0.000148	CbGpPWpGaD
Naproxen—ALB—Hemostasis—TP53—ulcerative colitis	2.59e-06	0.000146	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ALB—ulcerative colitis	2.5e-06	0.000141	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ADCY5—ulcerative colitis	2.46e-06	0.000139	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPARG—ulcerative colitis	2.26e-06	0.000128	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ABCB1—ulcerative colitis	2.26e-06	0.000127	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPARG—ulcerative colitis	2.25e-06	0.000127	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ADCY5—ulcerative colitis	2.11e-06	0.000119	CbGpPWpGaD
Naproxen—PTGS2—Disease—STAT3—ulcerative colitis	2.03e-06	0.000115	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ALB—ulcerative colitis	2.03e-06	0.000115	CbGpPWpGaD
Naproxen—PTGS2—Disease—TGFB1—ulcerative colitis	1.88e-06	0.000106	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.84e-06	0.000104	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PTGS2—ulcerative colitis	1.78e-06	0.0001	CbGpPWpGaD
Naproxen—ALB—Metabolism—PTGS2—ulcerative colitis	1.77e-06	9.97e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ALB—ulcerative colitis	1.65e-06	9.33e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPARG—ulcerative colitis	1.57e-06	8.87e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PTGS2—ulcerative colitis	1.45e-06	8.16e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6—ulcerative colitis	1.42e-06	8.02e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALB—ulcerative colitis	1.41e-06	7.97e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.24e-06	6.98e-05	CbGpPWpGaD
